News articles about Nu Skin Enterprises (NYSE:NUS) have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a news impact score of 0.10 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.9219389079218 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Nu Skin Enterprises (NUS) opened at $62.96 on Thursday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $3,349.59, a P/E ratio of 22.48, a price-to-earnings-growth ratio of 2.31 and a beta of 1.57. Nu Skin Enterprises has a twelve month low of $46.35 and a twelve month high of $65.85.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting the consensus estimate of $0.76. The firm had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The company’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 EPS. equities research analysts expect that Nu Skin Enterprises will post 3.23 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th will be issued a $0.36 dividend. The ex-dividend date is Thursday, November 16th. This represents a $1.44 annualized dividend and a yield of 2.29%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 52.75%.
Several brokerages recently weighed in on NUS. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday. Zacks Investment Research downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Finally, BidaskClub downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Nu Skin Enterprises has an average rating of “Hold” and an average price target of $62.00.
WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Nu Skin Enterprises (NUS) Share Price” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://ledgergazette.com/2017/11/16/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-nu-skin-enterprises-nus-share-price.html.
In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 36,503 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $62.24, for a total value of $2,271,946.72. Following the completion of the transaction, the insider now owns 66,563 shares of the company’s stock, valued at approximately $4,142,881.12. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Joseph Y. Chang sold 13,497 shares of the company’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $62.06, for a total value of $837,623.82. Following the completion of the transaction, the insider now directly owns 66,563 shares of the company’s stock, valued at approximately $4,130,899.78. The disclosure for this sale can be found here. In the last ninety days, insiders sold 73,207 shares of company stock valued at $4,585,949. Insiders own 5.20% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.